Renaissance Technologies’s Korsana Biosciences KRSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-1,516
Closed -$34.2K – 3526
2024
Q4
$34.2K Buy
+1,516
New +$29.5K ﹤0.01% 3432
2023
Q2
– Sell
-619
Closed -$38K – 3984
2023
Q1
$38K Sell
619
-692
-53% -$61.1K ﹤0.01% 3713
2022
Q4
$120K Sell
1,311
-713
-35% -$59K ﹤0.01% 3562
2022
Q3
$244K Sell
2,024
-1,234
-38% -$148K ﹤0.01% 3296
2022
Q2
$250K Buy
3,258
+1,097
+51% +$110K ﹤0.01% 3550
2022
Q1
$336K Sell
2,161
-310
-13% -$52.3K ﹤0.01% 3417
2021
Q4
$595K Buy
2,471
+1,955
+379% +$646K ﹤0.01% 2993
2021
Q3
$222K Sell
516
-1,518
-75% -$695K ﹤0.01% 3170
2021
Q2
$1.11M Buy
2,034
+368
+22% +$161K ﹤0.01% 2622
2021
Q1
$651K Buy
1,666
+1,538
+1,202% +$809K ﹤0.01% 2804
2020
Q4
$55K Buy
+128
New +$61.1K ﹤0.01% 3312
2020
Q3
– Sell
-607
Closed -$502K – 3423
2020
Q2
$502K Buy
607
+208
+52% +$122K ﹤0.01% 2874
2020
Q1
$148K Buy
+399
New +$199K ﹤0.01% 3160

Other funds holding KRSA

Renaissance Technologies's KRSA Position: Q1 2025 in Review

Renaissance Technologies sold out of Korsana Biosciences (KRSA) in Q1 2025, closing a stake of 1,516 shares — an estimated $34.2K sold.

Renaissance Technologies first reported a position in KRSA in Q1 2020 and held it in 13 quarters. The position peaked at $1.11M in Q2 2021. 17 funds tracked by Wall St. Rank hold KRSA as of Q1 2025.

  • Renaissance Technologies reported no remaining Korsana Biosciences position as of Q1 2025 after selling out during the quarter.
  • Renaissance Technologies sold 1,516 Korsana Biosciences shares in Q1 2025, an estimated $34.2K.
  • Renaissance Technologies first reported a position in Korsana Biosciences in Q1 2020 and held it in 13 quarters.
  • Renaissance Technologies's Korsana Biosciences position peaked at $1.11M in Q2 2021.
  • 17 funds tracked by Wall St. Rank held Korsana Biosciences as of Q1 2025.

Based on Renaissance Technologies's 13F filing for Q1 2025, filed 14 May 2025.